semaglutide for heart disease ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome Heart disease: Semaglutide may reduce

Emerging data also suggest potential renoprotective effects, offering hope for managing or preventing CKD in patients with diabetes or hypertension

Supplementary Table 1 (download XLSX Screen data

A random-effects meta-analysis yielded a pooled odds ratio (OR) of 1.49 (95% CI 1.181.88), indicating a 49% relative increase in the risk of depression-related outcomes among GLP-1 RA users compared with controls (Fig

Yes, you might need to change your diet if you plateau

A recent study from Prime Therapeutics found that nearly half of patients discontinue GLP-1 therapy within the first year, and three out of four stop treatment by year two